Beta Drugs Limited (NSE:BETA)
India
· Delayed Price · Currency is INR 1,098.00
+30.20 (2.83%)
At close: Mar 6, 2026
Beta Drugs Company Description
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India.
The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI).
The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
Beta Drugs Limited
| Country | India |
| Founded | 1985 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 399 |
Contact Details
Address: SCO-184 Panchkula, Himachal Pradesh 134114 India | |
| Phone | 91 17 2258 5481 |
| Website | betadrugslimited.com |
Stock Details
| Ticker Symbol | BETA |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Rahul Batra | Chairman and MD |
| Varun Batra | Joint MD and Whole Time Director |
| Nipun Arora | Chief Financial Officer |
| Rajni Brar | Company Secretary and Compliance Officer |
| Balwant Singh | Whole Time Director |
| Ashutosh Shukla | Vice President of Sales and Marketing and Whole Time Director |